Huntington's Disease-Induced Cardiac Disorders Affect Multiple Cellular Pathways

Girish C Melkani1

  • 1Department of Biology, Molecular Biology and Heart Institutes, San Diego State University, San Diego, CA 92182, USA.

Reactive Oxygen Species (Apex, N.C.)
|July 3, 2018
PubMed

Insights

Huntington's disease (HD), a neurological disorder, also significantly impacts heart health, leading to cardiovascular issues like cardiac amyloidosis. Further research is crucial to understand and treat these heart complications in HD patients.

Area of Science:

  • Neurology
  • Cardiology
  • Genetics

Background:

  • Huntington's disease (HD) is a rare, inherited neurodegenerative disorder caused by expanded polyglutamine repeats in the huntingtin protein.
  • While primarily affecting the central nervous system, heart disease is a leading cause of mortality in HD patients.
  • Emerging evidence links HD to cardiovascular diseases, including cardiac amyloidosis.

Purpose of the Study:

  • To review and synthesize published literature on pathological factors contributing to HD-induced cardiac amyloidosis and other cardiovascular diseases.
  • To identify gaps in current understanding regarding the mechanisms of HD-induced cardiac pathology and its cell autonomy.
  • To highlight the need for further comprehensive studies on cardiac function in HD patients.

Main Methods:

  • Literature review of experimental animal and clinical studies.
  • Analysis of pathological factors such as protein misfolding, autophagic defects, oxidative stress, mitochondrial dysfunction, and cell death.
  • Examination of the association between HD and peripheral muscle pathophysiology.

Main Results:

  • HD is increasingly recognized as a complex disease with significant peripheral manifestations in cardiac and skeletal muscles.
  • Several mechanisms are implicated in HD-induced cardiac pathology, including protein misfolding and mitochondrial dysfunction.
  • Despite progress, the precise mechanisms and cell autonomy of HD-induced cardiac pathology remain unclear.

Conclusions:

  • HD's impact extends beyond the nervous system to include significant cardiac pathology, particularly cardiac amyloidosis.
  • Further investigation into the mechanisms of HD-induced cardiac disease is essential.
  • Comprehensive studies are needed to develop therapeutic strategies to mitigate cardiac complications and improve outcomes for HD patients.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...